Working together with IBT
IBT collaborates with academic institutions, clinicians, biotechnology companies, and medical device innovators to accelerate the development and translation of breakthrough therapies. Through a combination of scientific expertise, translational research infrastructure, GLP-compliant preclinical testing, and deep regulatory experience, IBT provides end-to-end support spanning concept refinement, benchtop and large animal evaluation, clinical strategy, and FDA pathway navigation. Leveraging close ties with the University of Michigan and a multidisciplinary team of physicians, veterinarians, engineers, and scientists, IBT offers a uniquely integrated environment for advancing novel extracorporeal therapies, biomaterials, and critical care technologies from innovation to real-world clinical impact.